Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Other Operating Expenses (2016 - 2025)

Nephros (NEPH) has 16 years of Other Operating Expenses data on record, last reported at $34000.0 in Q3 2025.

  • For Q3 2025, Other Operating Expenses changed 0.0% year-over-year to $34000.0; the TTM value through Sep 2025 reached $142000.0, down 5.96%, while the annual FY2024 figure was $135000.0, 36.02% down from the prior year.
  • Other Operating Expenses reached $34000.0 in Q3 2025 per NEPH's latest filing, down from $35000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $54000.0 in Q4 2022 and bottomed at -$365000.0 in Q4 2021.
  • Average Other Operating Expenses over 5 years is $21315.8, with a median of $43000.0 recorded in 2021.
  • The widest YoY moves for Other Operating Expenses: up 1150.0% in 2021, down 830.0% in 2021.
  • A 5-year view of Other Operating Expenses shows it stood at -$365000.0 in 2021, then surged by 114.79% to $54000.0 in 2022, then decreased by 5.56% to $51000.0 in 2023, then plummeted by 33.33% to $34000.0 in 2024, then changed by 0.0% to $34000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $34000.0 in Q3 2025, $35000.0 in Q2 2025, and $39000.0 in Q1 2025.